According to the latest report by IMARC Group, titled " Pet Cancer Therapeutics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026," the global pet cancer therapeutics market reached a value of US$ XX Million in 2020. Looking forward, IMARC Group expects the market to grow at a CAGR of XX% during 2021-2026.

We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.

Request Free Report Sample: https://www.imarcgroup.com/pet-cancer-therapeutics-market/requestsample

Pet cancer therapeutics stands for the diagnosis and treatment alternatives for cancerous and tumor growth in domesticated animals. It involves treating mast cell cancer, melanoma, mammary, and squamous cell cancer, lymphoma, etc., in dogs, cats, and other pet animals. Some commonly utilized therapeutics include chemotherapy, immunotherapy, radiation therapy, etc. Pet cancer therapeutics shrink the cancer cells using bacteria- and plant-based drugs and prevent the tumor from affecting numerous body parts. The drugs are administered orally, under the skin, or into a muscle. They can be mixed with the food to make it more appealing for the pets.

The rising prevalence of cancer in animals across the globe is primarily driving the pet cancer therapeutics market. Furthermore, the increasing domestication of animals and escalating concerns towards pet health are also propelling the market growth. Besides this, continuous technological advancements, including launch of highly targeted and specific therapies for animal cancer treatment with minimal side effects, are also positively influencing the market. Additionally, the rising expenditure capacities of the consumers and various R&D activities in veterinary oncology will continue to propel the pet cancer therapeutics market over the forecasted period.

Pet Cancer Therapeutics Market 2021-2026 Competitive Analysis and Segmentation:

Competitive Landscape With Key Players:                         

The competitive landscape of the global pet cancer therapeutics market has been studied in the report with the detailed profiles of the key players operating in the market.

Competitive Landscape with Key Players:

  • AB Science
  • Boehringer Ingelheim International GmbH
  • Elanco Animal Health Incorporated
  • ELIAS Animal Health LLC
  • Karyopharm Therapeutics
  • Pfizer Inc.
  • Regeneus Ltd.
  • Rhizen Pharmaceuticals AG
  • Torigen Pharmaceuticals Inc.
  • VetDC Inc.
  • Virbac
  • Zoetis Inc.

Key Market Segmentation:

The report has segmented the global pet cancer therapeutics market on the basis of therapy, animal species, cancer type, end user and region.

Breakup by Therapy:

  • Chemotherapy
  • Radiation Therapy
  • Immunotherapy
  • Combination Therapy
  • Others

Breakup by Animal Species:

  • Cats
  • Dogs
  • Others

Breakup by Cancer Type:

  • Lymphoma
  • Mast Cell Cancer
  • Melanoma
  • Mammary and Squamous Cell Cancer
  • Others

Breakup by End User:

  • Veterinary Hospitals and Clinical Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Others

Breakup by Region:

  • North America
  • Asia-Pacific
  • Europe
  • Latin America
  • Middle East and Africa

Explore Full Report with TOC & List of Figure: https://bit.ly/2XT1oML

Key highlights of the report:            

  • Market Performance (2015-2020)
  • Market Outlook (2021-2026)
  • Industry Trends
  • Market Drivers and Success Factors
  • The Impact of COVID-19 on the Global Market
  • Value Chain Analysis
  • Structure of the Global Market
  • Comprehensive mapping of the competitive landscape

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us                              

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US:

IMARC Group
30 N Gould St, Ste R
Sheridan, WY 82801, USA
Email: sales@imarcgroup.com
Americas: +1-631-791-1145 | Europe & Africa: +44-753-713-2163 | Asia: +91-120-433-0800